Form 4: Verrica Pharmaceuticals COO Awarded 950,000 Stock Options

Verrica Pharmaceuticals' Chief Operating Officer, David Zawitz, was granted 950,000 stock options on December 9, 2024, which vest over time.

Summary

• David Zawitz, the Chief Operating Officer of Verrica Pharmaceuticals, was granted 950,000 employee stock options on December 9, 2024.
• The exercise price of these options is $0.95 per share.
• The options vest over time, with 1/8th vesting on June 9, 2025, and the remaining 47/48ths vesting monthly thereafter, contingent on continuous service.
• The options expire on December 9, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management and shareholder interests. There are no negative implications.

Positives

• The grant of stock options aligns the COO's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the COO.

Risks

• The value of the options is dependent on the future performance of Verrica Pharmaceuticals' stock price.
• If the COO leaves the company before the options fully vest, they may forfeit some or all of the options.

Future Outlook

The stock options will vest over time, contingent on the COO's continued employment with the company.

Industry Context

Stock option grants are a common form of executive compensation in the pharmaceutical industry, used to incentivize performance and align management interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a standard practice for compensating executives in publicly traded companies, particularly in the biotech and pharmaceutical sectors.
• The vesting schedule of 1/8th after 6 months and then monthly is a fairly typical vesting schedule.
• The exercise price of $0.95 is a common practice to be at or near the current market price at the time of the grant.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes the COO to improve company performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, executive compensation, insider trading, vesting, Verrica Pharmaceuticals, VRCA, David Zawitz